Penicillin-binding protein · PROTEIN FAMILY · Staphylococcus aureus
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Penicillin-binding protein shows approved-linked disease relevance led by infection. 1 more disease program remain visible in the same review block. 3 linked drugs keep the current disease frame grounded. Protein identity stays anchored to UniProt P72355. Start with infection, then reuse UniProt P72355 as the stable protein anchor across project notes and exports.
Start with infection, then reuse UniProt P72355 as the stable protein anchor across project notes and exports.
Penicillin-binding protein shows approved-linked disease relevance led by infection. 1 more disease program remain visible in the same review block. 3 linked drugs remain visible in the same block.
Start review with infection because it currently carries approved-linked support. Linked drugs include DICLOXACILLIN SODIUM, NAFCILLIN SODIUM, OXACILLIN SODIUM. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
Disease source · ChEMBL drug mechanism + indication proxyPenicillin-binding protein 4
Review this target as Penicillin-binding protein, mapped to UniProt P72355. ChEMBL maps the protein component as Penicillin-binding protein 4. Sequence length is 431 aa.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Penicillin-binding protein as ChEMBL target CHEMBL2362972, mapped to UniProt P72355. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether Penicillin-binding protein is the right protein anchor across sources, using UniProt P72355 as the stable mapping.
Jump to Protein ContextUse this block first when you need to confirm why infection is currently framed as approved-linked support. It currently carries 3 linked drugs in the same disease frame.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | Penicillin-binding protein |
| Target Type | PROTEIN FAMILY |
| Organism | Staphylococcus aureus |
| UniProt | P72355 |
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | Penicillin-binding protein 4 |
| UniProt Accession | P72355 |
| Component Type | Protein |
| Sequence Length | 431 aa |
Penicillin-binding protein 4
Review this target as Penicillin-binding protein, mapped to UniProt P72355. ChEMBL maps the protein component as Penicillin-binding protein 4. Sequence length is 431 aa.
Open Targets-ready disease context using the current target-indication evidence contract.
Penicillin-binding protein shows approved-linked disease relevance led by infection. 1 more disease program remain visible in the same review block.
Start review with infection because it currently carries approved-linked support. Linked drugs include DICLOXACILLIN SODIUM, NAFCILLIN SODIUM, OXACILLIN SODIUM. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.